Pulmonology

Uzm. Dr. Ökkeş Gültekin

Doctor and researcher Kemalpaşa Devlet Hastanesi İzmir
COVID-19
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPulmonologysaglik.gov.trFrom source
  • Department name at the sourceGöğüssaglik.gov.trFrom source
  • InstitutionKemalpaşa Devlet Hastanesisaglik.gov.trFrom source
  • Area of workCOVID-19Extracted from 4 publications · Model version —From source
  • Publications20 publicationsEurope PMC, OpenAlexFrom source
  • ORCID0000-0001-9753-8744ORCIDFrom source
  • Last synchronised5 November 2026 09:07https://kemalpasadh.saglik.gov.tr/TR-674899/gogus-poliklinigi.html#okkes-gultekinsaglik.gov.tr

Scientific work

Publications on COVID-19

20 publications
Publications by year Most: 4, in 2022
  1. 2019: 1 publication
  2. 2020: 1 publication
  3. 2021: 3 publications
  4. 2022: 4 publications
  5. 2023: 1 publication
  6. 2024: 4 publications
  7. 2025: 2 publications
  8. 2026: 4 publications

  1. Integration of CURB-65 and CT Severity Score for Prognostic Prediction in Community-acquired Pneumonia

    Thoracic research and practice, 2026

    DOI 10.4274/thoracrespract.2026.2026-5-6 PMID 42853027 Open-access full textSource: Europe PMC

  2. Twelve-month smoking cessation outcomes following immediate referral in people who smoke with chronic airway diseases: a randomized study

    Addiction science & clinical practice, 2026

    DOI 10.1186/s13722-026-00676-0 PMID 42121293 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  3. Methylprednisolone in the management of post-COVID-19 interstitial lung disease: A randomized trial (STERCOV-ILD).

    Sarcoidosis vasculitis and diffuse lung diseases, 2026

    DOI 10.36141/svdld.2026.17022 PMID 41891406 Open-access full textSource: OpenAlex

  4. Clinical Characteristics and Factors Associated with One-Year Smoking Cessation Among Smokers with COPD: A Subgroup Analysis of a Multicentre Randomised Trial

    International Journal of COPD, 2026

    DOI 10.2147/copd.s616474 PMID 42820089 Open-access full textSource: OpenAlex

  5. Immediately scheduled for an appointment to smoking cessation clinics: Key to quitting smoking in chronic airway disease – a multicenter randomized study

    Tobacco Induced Diseases, 2025

    DOI 10.18332/tid/204254 PMID 40475312 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  6. Impact of immediate appointment scheduling on quit success at first year follow ups: Mid-term outcomes of a randomized trial of smokers with chronic airway diseases

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa2672 Source: OpenAlex

  7. Post-COVID Interstitial Lung Disease: How do We Deal with This New Entity?

    Balkan medical journal, 2024

    DOI 10.4274/balkanmedj.galenos.2024.2024-3-82 PMID 39192585 5 citations (Europe PMC) Open-access full textSource: Europe PMC

  8. Effectiveness of immediate appointment scheduling in smoking cessation clinics for patients with chronic airway diseases: Preliminary results from a randomized trial

    Tobacco Induced Diseases, 2024

    DOI 10.18332/tid/191782 PMID 39184066 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  9. Immediate evidence-based support: Key to quitting smoking in chronic airway disease – A multicenter randomized study

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.rct1002 Source: OpenAlex

  10. The effect of immediate appointment scheduling on the rate of access to smoking cessation clinics for patients with chronic airway disease: Preliminary results of a randomized trial

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.oa4670 Source: OpenAlex

View all 20 publications